Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients

Patients with psoriasis are often affected by comorbidities, which largely influence treatment decisions. Here we performed conjoint analysis to assess the impact of comorbidities on preferences of patients with moderate-to-severe psoriasis for outcome (probability of 50% and 90% improvement, time u...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Autores principales: Schaarschmidt, Marthe-Lisa, Kromer, Christian, Herr, Raphael, Schmieder, Astrid, Sonntag, Diana, Goerdt, Sergij, Peitsch, Wiebke K.
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4669171/
https://ncbi.nlm.nih.gov/pubmed/26633680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0144335
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares